phrykt

Exicure, Inc. (XCUR): who owns it and who trades it

As of Nov 16, 2026, XCUR insiders reported 4 open-market sales worth $11.6M and no purchases in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Exicure HiTron Inc. (10% owner), with $7.8M. 1 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Exicure

From the latest filings

Overall: about as much buying as selling. Insiders mostly sold. Famous investors mostly bought.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Insider trades

In the last 12 months, XCUR insiders reported $0 of open-market purchases and $11.6M of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$11.6M
4 trades, 2 people
Sales under a 10b5-1 plan
0%
Share of sale value
Latest trade
Jan 21, 2026
Filed Jan 21, 2026

Purchases and sales by month

$7.8M$7.8MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Jan 21, 2026Exicure HiTron Inc.10% ownerSale258,367$4.50$1.2MForm 4
Jan 16, 2026Exicure HiTron Inc.10% ownerSale734,747$4.50$3.3MForm 4
Jan 7, 2026Exicure HiTron Inc.10% ownerSale741,272$4.50$3.3MForm 4
Dec 8, 2025Sangsangin Investment & Securities Co., Ltd.10% ownerSale433,332$8.71$3.8MForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Exicure HiTron Inc.10% owner–$7.8MJan 21, 2026
Sangsangin Investment & Securities Co., Ltd.10% owner–$3.8MDec 8, 2025
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

XCUR short interest

Low short interest. 0.8% of XCUR shares are sold short: about 1 share in 122. Over the last 12 reports the number of shares short went up 62%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 52,218 XCUR shares were sold short, 0.8% of the shares outstanding, up 21.7% from the report before. At the average daily volume of 76,751 shares, buying them all back would take about 1.0 trading days (days to cover).

Shares short, % of all shares

0.82%May 15Oct 309.13%

Days to cover

1.0May 15Oct 302.6

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 202652,2180.82%+22%76,7511.0
Oct 15, 202642,8920.67%+14%40,6651.1
Sep 30, 202637,5610.59%-47%18,7632.0
Sep 15, 202670,6721.11%+39%44,4491.6
Aug 31, 202650,8260.80%-16%46,9291.1
Aug 14, 202660,4020.95%-44%43,7271.4
Jul 31, 2026107,4701.69%-79%138,7571.0
Jul 15, 2026506,7297.95%+7428%2.15M1.0
Jun 30, 20266,7310.11%-54%70,8861.0
Jun 15, 202614,7570.23%-29%20,4351.0
May 29, 202620,8340.33%-35%14,4681.4
May 15, 202632,2900.51%-38%13,6412.4

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Exicure company events

Exicure filed 12 reports on Form 8-K in the last 12 months, 6 of them about an important change (leadership, listing). The latest was on Nov 10, 2026.

  1. Nov 10, 2026AgreementExicure, Inc., a Delaware corporation, and its wholly owned subsidiary, GPCR Therapeutics USA Inc., a California corporation, entered into an Intellectual Property, Asset and License Assignment Agreement with GPCRT Inc., a corporation organized under the laws of the Republic of Korea, pursuant to… Filing
  2. Sep 16, 2026ListingNasdaq Extension to Regain Compliance with Stockholders’ Equity Requirement As previously disclosed, on June 5, 2026, Exicure, Inc. received a notification letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC indicating that the Company was not in compliance with Nasdaq… Filing
  3. Jun 30, 2026LeadershipHam Jung Kyu resigned from the Board of Directors of Exicure, Inc., effective as of June 30, 2026. Filing
  4. Jun 1, 2026AnnouncementShared information with investors. Filing
  5. Apr 10, 2026LeadershipThe Board of Directors of Exicure, Inc. appointed Yoontae Han to serve as a director of the Company, effective as of April 8, 2026, until a successor has been duly elected and qualified or until his earlier death, resignation or removal, as a director of the Company. Filing
  6. Apr 2, 2026AnnouncementThe United States District Court for the Northern District of Illinois preliminarily approved the settlement of stockholder derivative claims brought on behalf of Exicure, Inc., as well as potential claims asserted by certain Exicure stockholders, in accordance with that certain Stipulation and… Filing
  7. Mar 27, 2026LeadershipSangjin Yeo submitted his resignation from the Board of Directors and the Audit Committee of the Board of Exicure, Inc., effective as of March 27, 2026. Filing
  8. Mar 25, 2026ResultsReleased financial results. Filing
  9. Feb 17, 2026LeadershipThe board of directors of Exicure, Inc. appointed Jung Soo Kim as the Chief Executive Officer and President of the Company, and also appointed Gyuyeob Lee as the Interim Chief Financial Officer and Secretary of the Company, each effective as of February 11, 2026. Filing
  10. Feb 10, 2026Leadership(i) Andy Yoo, (ii) Seung Ik Baik, and (iii) Aejin Hwang resigned from the Board of Directors of Exicure, Inc., effective February 9, 2026. Filing
  11. Jan 22, 2026AnnouncementExicure, Inc. achieved the first contractual milestone under its License and Collaboration Agreement with GPCR Therapeutics Inc. The milestone relates to the completion of the Company’s Phase 2 clinical trial of its novel stem cell mobilizer (NCT05561751), which was achieved through the formal… Filing
  12. Nov 17, 2025AnnouncementExicure, Inc. redeemed in full the 4.5 billion KRW, approximately $3.125 million USD, of 2.90% Convertible Bonds due 2028 previously issued by its wholly owned subsidiary, KC Creation Co., Ltd., and held by the Company. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Exicure financials

Famous investors that hold XCUR

1 of the 50 well-known investors we track reported holding XCUR in their latest 13F filing. The largest position is Ken Griffin's, worth $98.9K.

FundQuarterSharesValueOf portfolioChange
Ken Griffin · Citadel AdvisorsQ3 202685,993$98.9K0.0%+476%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

Questions about Exicure, Inc. (XCUR) stock

Are XCUR insiders buying or selling?

In the last 12 months, XCUR insiders reported no open-market purchases and 4 sales worth $11.6M. The latest trade was on Jan 21, 2026. See every trade.

What is the short interest in XCUR?

As of Oct 30, 2026, 52,218 XCUR shares were sold short, 0.8% of the shares outstanding, up 21.7% from the report before. At the average daily volume of 76,751 shares, buying them all back would take about 1.0 trading days (days to cover). See the history.

Which famous investors hold XCUR?

1 of the 50 well-known investors we track reported XCUR in their latest 13F filing, including Ken Griffin. The largest position is worth $98.9K. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.